“We have previously reported the antineoplastic effects of a cannabinoid agonist in gastric cancer cells. Our aim was to evaluate this in a murine xenograft model…
Conclusion: WIN 55,212-2 has antineoplastic effect on the gastric cancers in in vivo model.”